THE ROLE OF ANTHRACYCLINES IN THE TREATMENT OF GASTRIC-CANCER

被引：16

作者：

WADLER, S ^{[1
]}

GREEN, M ^{[1
]}

MUGGIA, F ^{[1
]}

机构：

[1] NYU MED CTR,SCH MED,RITA & STANLEY H KAPLAN CANC CTR,DIV MED ONCOL,NEW YORK,NY 10016

来源：

CANCER TREATMENT REVIEWS | 1985年 / 12卷 / 02期

关键词：

D O I：

10.1016/0305-7372(85)90003-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：105 / 132

页数：28

共 96 条

[1]

AHLGREN JD, 1984, P AN M AM SOC CLIN, V3, P145

[2]

ARROSTOA J, 1985, P AM SOC CLIN ONCOL

[3]

BAKER LH, 1976, CANCER-AM CANCER SOC, V38, P1, DOI 10.1002/1097-0142(197607)38:1<1::AID-CNCR2820380102>3.0.CO

[4]

2-S

[5]

BAKER LH, 1979, CANCER TREAT REP, V63, P899

[6] PHASE-II EVALUATION OF DIHYDROXYANTHRACENEDIONE (DHAD, NSC301739) IN PATIENTS WITH UPPER GASTROINTESTINAL TUMORS - A PRELIMINARY-REPORT [J].

BEDIKIAN, AY ;

STROEHLEIN, J ;

KORINEK, J ;

KARLIN, D ;

VALDIVIESO, M ;

BODEY, GP .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04) :473-476

[7] A PHASE-II STUDY OF CISPLATIN IN ADVANCED GASTRIC-CANCER [J].

BEER, M ;

COCCONI, G ;

CECI, G ;

VARINI, M ;

CAVALLI, F .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (06) :717-720

[8]

BERETTA G, 1982, P AN M AM SOC CLIN, V1, P103

[9]

BIRAN H, 1984, P AN M AM SOC CLIN, V3, P132

[10]

BITRAN JD, 1979, CANCER TREAT REP, V63, P2049

← 1 2 3 4 5 6 7 8 9 10 →